Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial
对患有慢性活动性乙型肝炎且无法切除的肝细胞癌患者,及时启动度伐利尤单抗和曲美利木单抗治疗:一项 II 期临床试验
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-02978-7
Shao, Yu-Yun; Chen, Ching-Tso; Chuang, Chien-Huai; Su, Tung-Hung; Ho, Ming-Chih; Tseng, Tai-Chung; Liu, Tsung-Hao; Wu, Tsung-Che; Cheng, Ann-Lii; Hsu, Chih-Hung